Re:Cognition Health is a UK-based startup that offers specialist cognitive healthcare services and supports clinical trial patient recruitment at its clinics in the UK and the USA. The company has garnered recognition for its award-winning private mental health services, which encompass neurology, psychology, and psychiatry, catering to a range of conditions such as ADHD, Autism, Alzheimer's disease, Parkinson's disease, migraine, and mild Traumatic Brain Injury.
As a world-leading memory clinic, Re:Cognition Health is actively involved in ongoing Alzheimer’s research and trials in collaboration with global pharmaceutical companies. The company is driven by its dedication to achieving better dementia and memory loss outcomes, ultimately striving for an Alzheimer’s cure.
The startup's vision is to emerge as the recognized leader in the diagnosis, treatment, and care management of individuals experiencing cognitive impairment. With clinics in key UK locations like London, Guildford, Birmingham, and Plymouth, as well as a presence in Virginia, USA, Re:Cognition Health is accessible to volunteers seeking new-generation treatments.
Established in 2011, Re:Cognition Health operates in the Health Care industry and is committed to providing the best clinical quality and customer experience in mental health diagnostic and treatment services. The company welcomes inquiries through its website or by calling 02033553536.
Although information on the latest investment and investors is not available at present, Re:Cognition Health continues to demonstrate its dedication to advancing cognitive healthcare and contributing to Alzheimer's research and treatment.